Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Thrombin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 51Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA clears J&J and Grifols' blood-stopping protein spray for surgical bleeds
    FDA clears J&J and Grifols' blood-stopping protein spray for surgical bleeds

    20 Jun 2019

    // Conor Hale FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/fda-clears-j-j-and-grifols-protein-spray-for-clotting-surgical-bleeds

    Conor Hale FIERCE BIOTECH
    20 Jun 2019
    Share Share
    Instituto Grifols, S.A. VeraSeal (human fibrinogen / human thrombin) Receives Approval In Europe
    Instituto Grifols, S.A. VeraSeal (human fibrinogen / human thrombin) Receives Approval In Europe

    19 Jan 2018

    // EMA

    https://www.pharmacompass.com/pdf/news/instituto-grifols-sa-veraseal-human-fibrinogen-human-thrombin-receives-approval-in-europe-1516426069.pdf

    EMA
    19 Jan 2018
    Share Share
    Mallinckrodt Diversifies Hospital Growth Portfolio,Acquiring 3 Stage…
    Mallinckrodt Diversifies Hospital Growth Portfolio,Acquiring 3 Stage…

    18 Dec 2015

    // PR NEWS WIRE

    http://www.prnewswire.com/news-releases/mallinckrodt-diversifies-hospital-growth-portfolio-acquiring-three-commercial-stage-global-specialty-hemostasis-brands-from-the-medicines-company-300195164.html

    PR NEWS WIRE
    18 Dec 2015
    Share Share